The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal...
The team developed a computational metabolite exchange scoring system to identify microbial cross feeding relationships--the use of metabolites produced...
Executives from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine will present on the impact of AI on biotechnology...
Researchers developed a technology called TEMPO, which integrates microvolume liquid-biopsy proteomics, single-cell transcriptomics, and AI, to map almost...
The number one thing most people fear as they age is developing dementia. As the world’s population becomes increasingly older, this is a growing public...
Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical advice...
Digitization of clinical trials isn’t particularly new. Today, electronic data capture is only one of myriad technologies deployed in clinical trials...
In this GEN webinar, Dr. Shelby Wyatt from Flywheel will discuss how AI-based medical imaging helps imaging/data scientists, innovators, and healthcare...
Laronde and Senda Biosciences, two biotech startups founded by Flagship Pioneering that collectively raised more than $750 million, are merging to form...
What Some Call "Anti-Science" Is Just Anti-Authoritarianism Authored by Alex Washburne via The Brownstone Institute, Sometimes it feels...
Cytiva and Bayer share a vision of the challenges limiting the advancement of allogeneic cell therapy and believe that together they can overcome these...
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis,...
A newly launched, first-of-its-kind institute aims to address a glaring gap in the medical system by working to integrate food-based nutrition interventions...
MIAMI, FLORIDA (Oct. 18, 2023) – Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of...
The goal of mRNA technology is to harness the power of the cell to potentially prevent infections and treat diseases.
By William Haseltine Regenerative medicine has emerged as a promising treatment option for chronic medical conditions. Specifically, cell and gene therapies,...
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing...
Some viruses can be dormant throughout a person’s life and cause no harm but become dangerous when the immune system is weakened. One of such viruses...
Researchers at University of California San Diego have discovered a process in which liver cells share molecules via vesicle exchange in order to multiply...
A recent paper by Ben et al. (2023) provides an R tutorial for implementing economic evaluations–often cost effectiveness analyses–using data from...
Andrea Califano, Dr, has been honored with the 26th Alfred G. Knudson Award in Cancer Genetics by the National Cancer Institute (NCI) for his exceptional...
Researchers used single-cell RNA sequencing (scRNA-seq) to identify a pattern of gene expression that can predict whether or not neurons will regenerate...
Patients with a previous or current cancer diagnosis are more likely to have a stroke than the general population, but how are specific cancers and treatments...
Former DEA chiefs and retired White House drug czars are expressing concerns over the possible cannabis rescheduling. In a letter addressed to U.S. Attorney General Merrick...
Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine (“Insilico”) has been invited to present scientific data on its...
Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons fail...
Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to...
Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to...
"We Can't Force The Human Body To Accept Foreign Genetic Code'' Dr. McCullough On mRNA Technology Authored by Naveen Athrappully via The Epoch...
A New "Brave New World" Authored by Raw Egg Nationalist via The Epoch Times (emphasis ours), For the past century, it’s been a mainstay...